Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Spire Wealth Management

Spire Wealth Management boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,722 shares of the medical equipment provider’s stock after acquiring an additional 3,404 shares during the quarter. Spire Wealth Management’s holdings in Intuitive Surgical were worth $11,338,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in ISRG. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock valued at $15,357,560 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $571.88 on Friday. The company has a market capitalization of $203.69 billion, a price-to-earnings ratio of 89.22, a PEG ratio of 5.52 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a fifty day moving average of $550.40 and a two-hundred day moving average of $508.94.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ISRG. Robert W. Baird raised their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. BTIG Research raised their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.